TY - JOUR
T1 - GEC-ESTRO ACROP recommendations in skin brachytherapy
AU - Guinot, Jose L.
AU - Rembielak, Agata
AU - Perez-Calatayud, Jose
AU - Rodríguez-Villalba, Silvia
AU - Skowronek, Janusz
AU - Tagliaferri, Luca
AU - Guix, Benjamin
AU - Gonzalez-Perez, Victor
AU - Valentini, Vincenzo
AU - Kovacs, György
PY - 2018
Y1 - 2018
N2 - Purpose: The aim of this publication is to compile available literature data and expert experience regarding skin brachytherapy (BT) in order to produce general recommendations on behalf of the GEC-ESTRO Group. Methods: We have done an exhaustive review of published articles to look for general recommendations. Results: Randomized controlled trials, systemic reviews and meta-analysis are lacking in literature and there is wide variety of prescription techniques successfully used across the radiotherapy centers. BT can be delivered as superficial application (also called contact BT or plesiotherapy) or as interstitial for tumours thicker than 5 mm within any surface, including very irregular. In selected cases, particularly in tumours located within curved surfaces, BT can be advantageous modality from dosimetric and planning point of view when compared to external beam radiotherapy. The general rule in skin BT is that the smaller the target volume, the highest dose per fraction and the shortest overall length of treatment can be used. Conclusion: Skin cancer incidence is rising worldwide. BT offers an effective non-invasive or minimally invasive and relative short treatment that particularly appeals to elder and frail population.
AB - Purpose: The aim of this publication is to compile available literature data and expert experience regarding skin brachytherapy (BT) in order to produce general recommendations on behalf of the GEC-ESTRO Group. Methods: We have done an exhaustive review of published articles to look for general recommendations. Results: Randomized controlled trials, systemic reviews and meta-analysis are lacking in literature and there is wide variety of prescription techniques successfully used across the radiotherapy centers. BT can be delivered as superficial application (also called contact BT or plesiotherapy) or as interstitial for tumours thicker than 5 mm within any surface, including very irregular. In selected cases, particularly in tumours located within curved surfaces, BT can be advantageous modality from dosimetric and planning point of view when compared to external beam radiotherapy. The general rule in skin BT is that the smaller the target volume, the highest dose per fraction and the shortest overall length of treatment can be used. Conclusion: Skin cancer incidence is rising worldwide. BT offers an effective non-invasive or minimally invasive and relative short treatment that particularly appeals to elder and frail population.
KW - Brachytherapy
KW - Dose Fractionation, Radiation
KW - Humans
KW - Practice Guidelines as Topic
KW - Radiotherapy Dosage
KW - Recommendations
KW - Skin
KW - Skin Neoplasms
KW - Brachytherapy
KW - Dose Fractionation, Radiation
KW - Humans
KW - Practice Guidelines as Topic
KW - Radiotherapy Dosage
KW - Recommendations
KW - Skin
KW - Skin Neoplasms
UR - http://hdl.handle.net/10807/149091
UR - http://www.elsevier.com/locate/radonc
U2 - 10.1016/j.radonc.2018.01.013
DO - 10.1016/j.radonc.2018.01.013
M3 - Article
SN - 0167-8140
VL - 126
SP - 377
EP - 385
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
ER -